These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity. Zhou J, Dutch RE, Lamb RA. Virology; 1997 Dec 22; 239(2):327-39. PubMed ID: 9434724 [Abstract] [Full Text] [Related]
3. Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment. Philipp HC, Schroth B, Veit M, Krumbiegel M, Herrmann A, Schmidt MF. Virology; 1995 Jun 20; 210(1):20-8. PubMed ID: 7793071 [Abstract] [Full Text] [Related]
4. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence. Ortiz MA, Paez E. Virology; 1994 Jan 20; 198(1):155-68. PubMed ID: 8259650 [Abstract] [Full Text] [Related]
5. Activation of an influenza virus A/turkey/Oregon/71 HA insertion variant by the subtilisin-like endoprotease furin. Morsy J, Garten W, Rott R. Virology; 1994 Aug 01; 202(2):988-91. PubMed ID: 8030261 [Abstract] [Full Text] [Related]
6. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid. Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA. Virology; 1998 Sep 01; 248(2):264-74. PubMed ID: 9721235 [Abstract] [Full Text] [Related]
7. The hemagglutinin cleavability of a virulent avian influenza virus by subtilisin-like endoproteases is influenced by the amino acid immediately downstream of the cleavage site. Horimoto T, Kawaoka Y. Virology; 1995 Jul 10; 210(2):466-70. PubMed ID: 7618281 [Abstract] [Full Text] [Related]
8. Modification of the cleavage activation of the influenza virus hemagglutinin by site-specific mutagenesis. Garten W, Vey M, Ohuchi R, Ohuchi M, Klenk HD. Behring Inst Mitt; 1991 Jul 10; (89):12-22. PubMed ID: 1930091 [Abstract] [Full Text] [Related]
9. Probing the structure of influenza B hemagglutinin using site-directed mutagenesis. Rivera K, Thomas H, Zhang H, Bossart-Whitaker P, Wei X, Air GM. Virology; 1995 Feb 01; 206(2):787-95. PubMed ID: 7856092 [Abstract] [Full Text] [Related]
10. Mutational analysis of the arginine residues in the E2-E1 junction region on the proteolytic processing of the polyprotein precursor of rubella virus. Qiu Z, McDonald HL, Chen J, Hobman TC, Gillam S. Virology; 1994 May 01; 200(2):821-5. PubMed ID: 8178466 [Abstract] [Full Text] [Related]
11. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Khatchikian D, Orlich M, Rott R. Nature; 1989 Jul 13; 340(6229):156-7. PubMed ID: 2544809 [Abstract] [Full Text] [Related]
12. Role of individual oligosaccharide chains in antigenic properties, intracellular transport, and biological activities of influenza C virus hemagglutinin-esterase protein. Sugahara K, Hongo S, Sugawara K, Li ZN, Tsuchiya E, Muraki Y, Matsuzaki Y, Nakamura K. Virology; 2001 Jun 20; 285(1):153-64. PubMed ID: 11414815 [Abstract] [Full Text] [Related]
13. Evaluation of Glu11 and Gly8 of the H5N1 influenza hemagglutinin fusion peptide in membrane fusion using pseudotype virus and reverse genetics. Su Y, Zhu X, Wang Y, Wu M, Tien P. Arch Virol; 2008 Jun 20; 153(2):247-57. PubMed ID: 18030546 [Abstract] [Full Text] [Related]
14. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function. Langley WA, Thoennes S, Bradley KC, Galloway SE, Talekar GR, Cummings SF, Varecková E, Russell RJ, Steinhauer DA. Virology; 2009 Nov 25; 394(2):321-30. PubMed ID: 19755201 [Abstract] [Full Text] [Related]